A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• OTX2 is a key transcription factor implicated in medulloblastoma (MB) pathogenesis.
• OTX2 amplification and overexpression are common in group 3 and group 4 MB subtypes.

Purpose of the Study:

• To investigate the noncanonical role of OTX2 in group 3 MB alternative splicing.
• To elucidate the mechanisms by which OTX2 influences splicing and its impact on tumor progression.

Main Methods:

• Assessed OTX2 interactions with splicing regulator complexes.
• Analyzed OTX2's direct/indirect RNA binding capabilities.
• Identified OTX2-regulated splicing targets and their role in MB and rhombic lip development.

Main Results:

• OTX2 associates with splicing machinery and regulates a stem cell-specific splicing program.
• OTX2 influences alternative splicing, potentially independent of its DNA-binding functions.
• OTX2 controls a pro-tumorigenic splicing program mirroring human cerebellar rhombic lip origins.
• PPHLN1, an OTX2-regulated gene, is crucial in primitive stem cells; targeting its splicing reduces tumor growth and enhances survival.

Conclusions:

• OTX2-mediated alternative splicing is a critical driver of cell fate decisions in group 3 MB.
• Targeting OTX2's splicing functions presents a potential therapeutic strategy for medulloblastoma.